Immune substances may help antibody-based drugs fight cancer
5th Jan 2006, 22:42 GMT
A new study suggests that antibody-based cancer drugs might help patients more if they are given with substances that stimulate the immune system. This new study is the first to indicate that the drug trastuzumab, also known as Herceptin, may work better when it is followed by injections of interleukin 2 or 12. Both substances trigger the activity of immune cells known as natural killer cells.
Immune substances may help antibody-based drugs fight cancer related news:
- Immune Substances May Help Antibody-based Drugs Fight Cancer — ScienceDaily Headlines
- Immune Stimulants May Help Cancer Patients, Study Shows — RedOrbit News - Health
- New drug combo may boost cancer treatment — NewKerala Health News
- New class of anti-cancer drugs based on platinum — Science Blog -
- Anti-cancer drugs based on platinum — News-Medical News Feed
- Researchers Identify A New Class Of Anti-cancer Drugs Based On Platinum — ScienceDaily Headlines: Health & Medicine
- Statins Do Nothing to Fight Cancer, Analysis Finds — RedOrbit News - Health
- Pot-like substances help fight osteoporosis — Science Blog -
- CancerVax and Micromet Announce Merger Agreement — Radiology News from StratCenter.com
- Cholesterol Drugs Don't Fight Cancer — RedOrbit News - Health
Latest news from EurekAlert! - Cancer:
- Targeted cancer drugs may work by disrupting balance of cellular signals
- Studies examine colorectal cancer screening rates
- Higher red meat intake may increase risk for certain breast cancers
- U-M researchers use nanoparticles to target brain cancer
- 'Trojan Horse' agent halts bone metastasis in mice
- Increased patient demand for prostate test has serious implications for cancer services
- Novel regulatory mechanism identified for key tumor suppressor p53